Pseudomonas aeruginosa produces siderophores, pyoverdin and pyochelin, for high-affinity iron uptake. To investigate their contribution to P. aeruginosa infections, we constructed allelic exchange mutants from strain PAO1 which were deficient in producing one or both of the siderophores. When inoculated into the calf muscles of immunosuppressed mice, pyochelin-deficient and pyoverdin-deficient mutants grew and killed the animals as efficiently as PAO1. In contrast, the pyochelin-and pyoverdin-deficient (double) mutant did not show lethal virulence, although it did infect the muscles. On the other hand, when inoculated intranasally, all mutants grew in the lungs and killed immunosuppressed mice. Compared with PAO1, however, the pyoverdin-deficient mutant and the double mutant grew poorly in the lungs, and the latter was significantly attenuated for virulence. Irrespective of the inoculation route, the pyoverdin-deficient and doubly deficient mutants detected in the blood were significantly less numerous than PAO1. Additionally, in vitro examination demonstrated that the growth of the double mutant was extremely reduced under a free-iron-restricted condition with apotransferrin but that the growth reduction was completely canceled by supplementation with hemoglobin as a heme source. These results suggest that both pyoverdin and pyochelin are required for efficient bacterial growth and full expression of virulence in P. aeruginosa infection, although pyoverdin may be comparatively more important for bacterial growth and dissemination. However, the siderophores were not always required for infection. It is possible that non-siderophore-mediated iron acquisition, such as via heme uptake, might also play an important role in P. aeruginosa infections.
Iron is essential for almost all living organisms, including bacteria. The ability of pathogenic bacteria to acquire iron in hosts is absolutely essential for bacterial growth and infection (7, 24) . In animal hosts, iron is usually bound to proteins such as transferrin and lactoferrin in extracellular fluid and to ferritin, hemoglobin, and heme-containing enzymes in cells (26, 45) . To utilize such complexes as iron sources, bacteria generally possess some sophisticated mechanisms, which include an iron uptake system mediated by high-affinity iron chelators called siderophores and a system for heme uptake via specific receptors (18, 26, 45) .
Pseudomonas aeruginosa, a ubiquitous gram-negative rod, is considered an important opportunistic pathogen. It is highly pathogenic for individuals with compromised immunity; some infections involving this organism have a poor prognosis despite recent advances in antimicrobial chemotherapy (5, 14) . P. aeruginosa is known to produce two chemically distinct siderophores, pyoverdin (Pvd) and pyochelin (Pch), for high-affinity iron uptake (10, 11, 28) .
Pvd is a fluorescent dihydroxyquinoline derivative connected to a small peptide and contains hydroxamate and catecholate residues to chelate ferric ion, Fe (III) (42) . Pch is a structurally unique siderophore possessing phenolate, but neither a hydroxamate nor a catecholate moiety (12) . Pvd chelates Fe (III) in a 1:1 stoichiometry with high affinity (stability constant, 10 32 ) (42), whereas Pch binds Fe (III) in a 2:1 stoichiometry with comparatively low affinity (stability constant, 10 5 ) (11) . The genes pvdA (40) , pvdD (20) , and pvdE (19) are considered to encode enzymes responsible for Pvd synthesis, and similarly a pchDCBA operon (34) and pchEF genes (31) are responsible for Pch synthesis. The outer membrane proteins FpvA (29) and FptA (3) are characterized as specific receptors for Fe (III)-Pvd and Fe (III)-Pch complexes, respectively. Fe (III)-siderophore complexes bound to receptors are thought, generally in gram-negative bacteria, to be internalized into the periplasm across the outer membrane with energy transduced by the TonB protein from the cytoplasmic membrane (6, 30) .
Both Pvd and Pch have been shown to remove iron from transferrin and lactoferrin and to promote P. aeruginosa growth in media containing these iron-binding proteins or human serum (2, 36, 46) . Pvd is more active than Pch in this regard in vitro, leading to speculation of the primacy of Pvd over Pch for bacterial iron acquisition in vivo. The relationship between these siderophores and P. aeruginosa pathogenicity or virulence has also been studied. Pvd production was shown to be required for bacterial colonization of the lung in a rat infection model (28) and to correlate with lethal virulence in a burned-mouse infection model (23) . In these previous studies, Pvd production mutants obtained by mutagenesis with UV or chemical treatment or transposon insertion were used successfully. On the other hand, Pch was shown to promote bacterial growth and lethality when injected into the peritoneal cavities of mice simultaneously with a virulent mutant of P. aeruginosa strain PAO1, which was isolated by repetitive passage in mice (8) . These experimental facts have undoubtedly led to advanced understanding about the importance of Pvd and Pch and iron acquisition with them for P. aeruginosa infections. However, the comparative roles or importance of these siderophores in vivo are still unclear and have never been investigated systematically.
In this study, in order to address the comparative importance of Pvd and Pch production for P. aeruginosa infection, we constructed Pch-deficient, Pvd-deficient, and doubly deficient mutants from a wild-type strain of P. aeruginosa, PAO1, by a Construction of mutants. Allelic exchange mutagenesis of the P. aeruginosa chromosome was carried out with a system established by Schweizer (33) except that the ColE1 type vector and the source of the mobilization cassette used were pMT5059 and pMT5071 (37), respectively. The pMT5059 derivative carrying the pchD gene, pHT004, was digested with StuI for deletion of an internal part (0.83 kb) of the gene; into this plasmid was inserted a StuI-flanked Tc gene cartridge (1.6 kb) excised from pMT5056 (38) , resulting in pHT005. An 8.5-kb NotI fragment containing the mobilization cassette of pMT5071 was subsequently inserted into the NotI site of pHT005 carrying ⌬pchD::Tc. The plasmid thus constructed (pHT006) was conjugally mobilized from E. coli strain S17-1 to P. aeruginosa strain PAO1, and then P. aeruginosa transconjugants were selected on VB agar plates containing tetracycline. A colony of tetracycline-resistant transconjugants was next spread onto LB agar plates containing 5% sucrose and tetracycline for selection of an allelic exchange mutant, PAD02. The pMT5059 derivative carrying the pvdA gene, pHT001, was digested with BglII and StuI for deletion of an internal part (0.47 kb) of the gene and treated with the Klenow fragment of DNA polymerase I; into this plasmid was inserted a blunt-end ⍀Sm gene cartridge (2.0 kb) prepared from pHRP316 (27) , resulting in pHT010. The mobilization cassette was subsequently inserted into the NotI site of pHT010 carrying ⌬pvdA::⍀Sm. The plasmid generated (pHT012) was introduced into PAO1 and PAD02 as described above, and then transconjugants were selected on VB agar plates containing streptomycin. Each colony of streptomycin-resistant transconjugants, derived from PAO1 and PAD02, was next spread onto LB agar plates containing 5% sucrose and streptomycin for selection of allelic exchange mutants PAD06 and PAD07, respectively. When chromosomal DNAs of the mutants were subjected to PCRs under the same conditions as those described for amplification of normal pchD and pvdA genes (2.1 and 2.0 kb, respectively), size changes were observed in PCR products as expected (2.9 kb for pchD in PAD02 and PAD07; 3.5 kb for pvdA in PAD06 and PAD07), indicating that the expected allelic exchanges had successfully occurred in the mutants obtained. In addition, the mutants, as well as PAO1, were all sensitive to carbenicillin and chloramphenicol (the MICs of carbenicillin and chloramphenicol against the mutants in SMMCA supplemented with 1 M FeCl 3 were 64 and 16 g/ml, respectively), indicating that the vector plasmid which mediated the allelic exchange did not remain in the mutants.
Siderophore assays. P. aeruginosa strain PAO1 and its mutants were inoculated at approximately 10 6 CFU/ml into, and cultured in, 5 ml of SMMCA containing 1 M FeCl 3 . After 20 h, Pvd secreted was assayed by measuring the optical density (OD) of the culture supernatant at 405 nm (OD 405 ). The Pch assay was performed as described previously (2) with minor modifications. Three milliliters of the supernatant of the P. aeruginosa culture was made acidic with 0.3 ml of acetic acid and extracted with 1.5 ml of dichloromethane. The extracts were concentrated by evaporation and applied onto silica thin-layer plates for chromatography in chloroform-acetic acid-ethanol (90:5:2. Animal experiments. Male ddY mice (Japan SLC Ltd., Hamamatsu, Japan), 5 to 6 weeks old, were used. They were housed in cages in an experimental room at 22 Ϯ 2°C and 55 Ϯ 15% humidity and were provided commercial food and drinking water ad libitum. The mice received intraperitoneal injections of 3 mg of cyclophosphamide (Endoxane; Shionogi & Co., Ltd., Osaka, Japan) for immunosuppression 3 days before the bacterial inoculation. P. aeruginosa strains for inocula were first fully grown in SMMCA containing 40 M FeSO 4 for 16 h; then bacterial cells collected by centrifugation were suspended in SMMCA containing 1 M FeCl 3 , an iron-poor medium, and were cultured for an additional 4 h. Bacteria were harvested by centrifugation and were suspended and diluted appropriately in saline. Bacterial suspensions were inoculated into mice by injection into the calf muscles of both legs (25 l/muscle) under ether anesthesia or by instillation into the nostrils (40 l) under anesthesia with a mixture of ketamine and xyladine. At various times, the animals were sacrificed by collection of blood from the axillary vein under ether anesthesia, and then the calf muscles, in the case of intramuscular inoculation, or the lungs, in the case of intranasal inoculation, were removed. Tissue samples were homogenized in 2 ml of potassium phosphate buffer (33 mM; pH 7.0). The blood and tissue homogenates were appropriately diluted with the phosphate buffer and plated onto LB agar plates for assaying counts of viable bacteria. In these animal studies, we followed the animal experimentation guidelines of the Daiichi Pharmaceutical Co., Ltd., Animal Care and Use Committee.
In vitro growth assays. Assays were performed in 96-well round-bottom plates. For the examination of the effect of apotransferrin (apoTsf, from bovines; Life Technologies) on bacterial growth, apoTsf was dissolved and diluted twofold serially with SMMCA in the wells (40 l/well), to which was added SMMCA containing 20 M FeCl 3 and 40 mM sodium bicarbonate (50 l/well). The plates were placed at 37°C for 1 h under 5% CO 2 and 95% air for promoting iron chelation by apoTsf. Then each well was inoculated with P. aeruginosa strain PAO1 or one of its mutants (10 l of bacterial suspension in SMMCA) at approximately 10 5 CFU/ml and incubated further for 20 h under the same conditions. Bacterial growth was measured as the OD 590 of the culture in a microplate spectrophotometer (MultiScan Plus MKII; Flow Laboratories). When FeSO 4 or hemoglobin (bovine; Sigma) was used as a further supplement in the apoTsf-containing medium, their twofold serial dilutions in SMMCA (40 l/well) were mixed with SMMCA containing 20 M FeCl 3 , 40 mM sodium bicarbonate, and 50 M apoTsf (50 l/well).
Statistics. Significant differences between two groups were analyzed by Student's t test (for means) or by Fisher's exact probability test (for frequencies). Probability values below 0.05 were considered significant.
RESULTS
Characteristics of P. aeruginosa mutants constructed. We constructed P. aeruginosa mutants PAD02, PAD06, and PAD07, in which pchD, pvdA, and both genes of strain PAO1, respectively, were inactivated. It is known that pchD encodes a putative adenylate-forming enzyme responsible for Pch synthesis (34) and that pvdA encodes an L-ornithine N 5 -oxygenase responsible for Pvd synthesis (40) . To examine siderophore production by the mutants, we cultured them in SMMCA supplemented with 1 M FeCl 3 and assayed Pch and Pvd in culture supernatants. In this medium, in which the iron concentration was kept low for promoting siderophore production, the mutants were indistinguishable from PAO1 in their growth (Fig.  1A) . Whereas PAO1 as the control was capable of producing Pch and Pvd, mutants PAD02, PAD06, and PAD07 were defective in production of Pch, Pvd, and both siderophores, respectively ( Fig. 1B and C) .
In vivo growth and virulence of P. aeruginosa strain PAO1 and its mutants after intramuscular inoculation. To examine the infectivity of strain PAO1 and its siderophore production mutants, we first inoculated them intramuscularly into immunosuppressed mice. Viable bacteria in inoculation sites (the calf muscles) and the blood were assayed at 16 h postinoculation (hpi). Bacterial growth was evaluated as the increase in the number of viable cells in the muscles over that in the inoculum (approximately 10 6 CFU). The virulence of the bacteria was assessed as lethality in the mice.
Like the parental strain, PAO1, the Pch-deficient mutant, PAD02, and the Pvd-deficient mutant, PAD06, grew very efficiently in the muscles (increase in viable bacteria, approximately 3 orders of magnitude [ Table 2 ]). They were disseminated and detectable at 16 hpi in the blood (10 3 to 10 5 CFU/ ml), but the mean count of PAD06 was significantly smaller than that of PAO1 (P Ͻ 0.05 [ Table 2 ]). These mutants and PAO1 showed similar virulence in the mice by 24 hpi (Table 2) .
In contrast, the growth of the Pch-and Pvd-deficient mutant, PAD07, in the muscles was very poor (increase in viable bacteria, less than 1 order of magnitude), and the mutant was not detected in the blood (Ͻ10 2 CFU/ml) ( Table 2 ). These results were significantly different from those for PAO1 and the other FIG. 1. Growth (A) and production of siderophores Pch (B) and Pvd (C) by P. aeruginosa strain PAO1 and its allelic exchange mutants in SMMCA supplemented with 1 M FeCl 3 . A bacterial growth assay was performed in a 96-well plate (0.1 ml of culture/well), and the growth was measured as OD 590 in a SPECTRAmax (Molecular Devices, Sunnyvale, Calif.), which is a microplate spectrophotometer with incubation and mixing functions, after bacterial inoculations at approximately 10 6 CFU/ml. E, strain PAO1; ‚, the pchD-inactivated mutant, PAD02; ᮀ, the pvdA-inactivated mutant, PAD06; ϩ, the pchD-and pvdA-inactivated mutant, PAD07; ϫ, no inoculum (medium control). Pch (B) and Pvd (C) secreted into the culture supernatant were fluorometrically or photometrically measured as described in Materials and Methods; the values for Pch and Pvd amounts (fluorometric measurement with excitation at 350 nm and emission at 440 nm and OD 405 , respectively) were corrected by dividing by the values for bacterial growth (OD 590 ). 10 CFU Ϯ SDs in muscles or in 1 ml of blood. Values in parentheses represent bacterial growth, expressed as the mean of the increases in the count (each count in the group at 16 hpi minus the inoculum), in log 10 CFU. SDs for mean increases in the counts are theoretically identical to those for mean counts at 16 hpi.
b Number of dead mice/number of mice inoculated for observation of bacterial virulence.
c Significantly different (P Ͻ 0.05) from value for PAO1-inoculated group as calculated by Student's t test (for means) or Fisher's exact probability test (for frequencies).
d Significantly different (P Ͻ 0.01) from value for PAO1-inoculated group as calculated by Student's t test (for means) or Fisher's exact probability test (for frequencies). (Table 2) .
In vivo growth and virulence of P. aeruginosa strain PAO1 and its mutants after intranasal inoculation. Next, to examine further the infectivity of strain PAO1 and its siderophore production mutants, we inoculated them intranasally into immunosuppressed mice. Bacterial growth was evaluated as the increase in the number of viable cells at 12 hpi over that at 1 hpi (indicated as amounts of bacteria introduced; approximately 10 6 CFU expected) in the lungs. Also in this experiment, viable bacteria in the blood were assayed, and bacterial lethality in the mice was observed.
The Pch-deficient mutant, PAD02, grew efficiently in the lung (increase in viable bacteria, more than 2 orders of magnitude), as did the parental strain, PAO1 (Table 3 ). This mutant and PAO1 were detected in substantial amounts (10 4 to more than 10 5 CFU/ml) in the blood and similarly killed almost all of the mice by 24 hpi (Table 3) .
The Pvd-deficient mutant, PAD06, also grew in the lungs (increasing by more than 1 order of magnitude) and was detectable in the blood (10 2 to 10 4 CFU/ml) (Table 3) . However, the levels of growth in the lungs and detection in the blood of this mutant were significantly lower than those of PAO1 (P Ͻ 0.01 and P Ͻ 0.05, respectively [ Table 3 ]), in contrast to the result in the intramuscular infection model. The virulence of PAD06 appeared to be a little attenuated, because this mutant took somewhat longer to kill the mice than did PAO1 (Table 3).
The growth level of the doubly deficient mutant, PAD07, in the lungs (increase, less than 1 order of magnitude) was also significantly lower than that of PAO1 (P Ͻ 0.01 [ Table 3 ]). In contrast with the results in the intramuscular infection model, PAD07 was detectable in the blood (10 2 to 10 3 CFU/ml), although the counts were significantly lower than those of PAO1 (P Ͻ 0.01), and showed lethal virulence within 24 to 48 hpi (Table 3) . However, the virulence of PAD07 was also certainly attenuated in this lung infection model, because no mice died from its inoculation by 24 hpi, when almost all mice were dead from the PAO1 inoculation (the difference was significant: P Ͻ 0.01 [ Table 3 ]).
In vitro growth of P. aeruginosa strain PAO1 and its mutants under a free-iron-restricted condition and the effect of hemoglobin. As described above, mutant PAD07, in spite of its inability to produce Pch and Pvd, resulted in infections of immunosuppressed mice, suggesting the contribution of nonsiderophore-mediated iron acquisition to P. aeruginosa growth in vivo. We speculated on the possible participation of heme uptake and so conducted in vitro experiments to examine it.
To constitute a free-iron-restricted condition in vitro, similar to the condition in vivo, we used a host iron chelator protein, apoTsf. We first tested the effect of apoTsf on the growth of strain PAO1 and its mutants in SMMCA containing 10 M FeCl 3 and 20 mM sodium bicarbonate. As shown in Fig. 2A , the growth of the double mutant, PAD07, was reduced in a manner dependent on increased concentrations of apoTsf and was almost completely abolished at 25 M (2 mg/ml). The concentration of apoTsf was very similar to those of transferrin (including apo-form) in the sera of mice and humans (43) . The growth of the Pvd-deficient mutant, PAD06, was reduced partially by the addition of apoTsf at more than 12.5 M, but the growth of the Pch-deficient mutant and the parental strain was not affected at all (Fig. 2A) . The reduction in the growth of a Samples were collected from three or five mice a group at 1 and 12 hpi, respectively, and assayed for viable bacteria. Values are mean log 10 CFU Ϯ SDs in the lung or in 1 ml of blood. The detection limit of bacteria in the blood was 2.00 to 5.00; the limit values were included for calculation of the mean, if data were below the limit. Values in parentheses represent bacterial growth, expressed as the mean of the increases in the count (each count in the group at 12 hpi minus the mean count at 1 hpi), in log 10 CFU. SDs for the mean increases in the counts are theoretically identical to those for mean counts at 12 hpi.
d Significantly different (P Ͻ 0.01) from value for PAO1-inoculated group as calculated by Student's t test (for means) or Fisher's exact probability test (for frequencies).
FIG. 2.
Effects of apoTsf on the growth of P. aeruginosa strain PAO1 and its siderophore production mutants in SMMCA containing 10 M FeCl 3 and 20 mM sodium bicarbonate (A), and effects of supplementation with FeSO 4 (B) or hemoglobin (C) on their growth in the medium including 25 M apoTsf. Growth was measured as the end point OD 590 of culture 20 h after bacterial inoculation. E, strain PAO1; ‚, the Pch-deficient mutant, PAD02; ᮀ, the Pvd-deficient mutant, PAD06; F, the Pch-and Pvd-deficient mutant, PAD07; ϫ, no inoculum (medium control).
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on December 29, 2017 by guest http://iai.asm.org/ PAD07 and PAD06 in the medium including 25 M apoTsf was canceled by supplementation with FeSO 4 at 10 to 40 M (Fig. 2B) , indicating that the growth reduction was based on the restriction of available free iron. In this free-iron-restricted medium prepared by addition of 25 M apoTsf, where iron might be present as transferrin, we examined the effect of hemoglobin as a heme source on bacterial growth. Interestingly, the growth of mutants PAD07 and PAD06 was completely restored by supplementation with hemoglobin at 0.31 to 1.25 M (Fig. 2C) , concentrations much lower than those required for FeSO 4 . These results demonstrate that P. aeruginosa certainly possesses a high-affinity heme uptake system, as described recently (16, 25) .
DISCUSSION
In this study, we approached the impacts of siderophores on P. aeruginosa infections by using a set of allelic exchange mutants of strain PAO1 that were unable to produce Pch, Pvd, or both siderophores. Two kinds of infection models in immunosuppressed mice were used. The results obtained in the present study included novel findings and increased our understanding of the contribution of these siderophores to P. aeruginosa infections, since the mutants possessed the same genetic background except for mutations in the genes responsible for Pch and Pvd production.
Compared with the parental wild-type strain, PAO1, the Pvd-deficient mutant (PAD06) grew poorly in the lung (Table  3) and was detected as lower counts in the blood after both intramuscular and intranasal inoculations (Tables 2 and 3 ), but this was not the case for the Pch-deficient mutant (PAD02). These results indicate that Pvd production is more important than Pch production for P. aeruginosa growth in vivo and probably for its dissemination. The primacy of Pvd in vivo that we observed may be consistent with previous findings in animal infection models (23, 28) . Furthermore, it is well supported by previous in vitro findings that showed superior activities of Pvd over Pch in removing iron from transferrin and lactoferrin and promoting growth in media supplemented with serum or host iron-binding proteins (2, 36) .
On the other hand, a certain importance of Pch production for P. aeruginosa infection was also demonstrated in this study, because the Pch-and Pvd-deficient mutant (PAD07) showed clearly lower growth ability and virulence than the Pvd-deficient mutant (PAD06) in the intramuscular inoculation model (Table 2 ; P Ͻ 0.01 for all the differences in viable counts in the muscles and blood and in lethality) and a similar tendency also in the intranasal inoculation model (Table 3) . Together with the primacy of Pvd, our data indicate that both Pvd and Pch are required for efficient bacterial growth and full expression of virulence in P. aeruginosa infections.
Thus, we succeeded in showing experimentally the impact of siderophore production on P. aeruginosa infections. At the same time, however, we should mention unequivocally that neither Pch nor Pvd nor both siderophores were always required for P. aeruginosa infection and virulence, because the doubly deficient mutant (PAD07) was certainly able to persist or grow in the muscles and lungs (Tables 2 and 3 ) and showed substantial lethality after intranasal inoculation (Table 3) in immunosuppressed mice.
Before this study, Pvd of P. aeruginosa had been believed to be essential for bacterial colonization of the lungs in a rat infection model (28) and for virulence in a burned-mouse infection model (23) . Poole et al. showed that Pvd-deficient mutants could not colonize the lungs of rats when the bacteria (10 4 CFU) were introduced incorporated into agar beads (28) . The mutants used in the previous study, IA130 and IAJ40M1, had been generated from a PAO1 auxotroph, PAO25 (argF10 leu-10), by chemical treatment and from PAO1 by transposon insertion, respectively (1). Meyer et al. demonstrated that the Pvd-deficient mutants PAO6606 and PAO6609 had significantly reduced lethal virulence when inoculated (10 2 CFU) into burned mice (23); the mutants had been obtained from a methionine auxotroph of PAO1 (PAO6049) by UV mutagenesis (15) . Discrepancies between these previous results and ours might be due to differences in infection models, including immunological states of the animals, characters of the mutants used, and sizes of bacterial inocula. In our study, the artificial immunosuppression of the mice by cyclophosphamide treatment might be related to considerable virulence of the mutants, including the Pvd-deficient mutant (PAD06), but the immunosuppression was unavoidable because even the wildtype strain PAO1 did not cause infections without it (data not shown). In addition, although the inoculum size used by us (approximately 10 6 CFU) was larger than that in the previous studies, it was required for determining constantly the lethal virulence of PAO1 as the control in our models (data not shown). On the other hand, it is also of concern whether mutations not responsible for siderophore production, defined or undefined, might be implicated in the previous results, since the previous mutants used were generated by fundamentally unspecific mutagenesis and actually included some other mutations associated with the auxotrophy in some strains.
Our animal experiments posed the question of what could support iron acquisition in vivo and infections by the Pch-and Pvd-deficient mutant, PAD07. To gain insight into this question, we established a free-iron-restricted condition by using apoTsf, which was thought to partly reflect the host conditions, and performed in vitro examinations. As a result, it was clarified that the double mutant was able to utilize a heme source during its growth under such a condition (Fig. 2C) . We consider this experimental fact to be strong evidence for a possibility that heme uptake may be also involved in iron acquisition in vivo and infection by P. aeruginosa.
As another possibility, we cannot ignore the effect of pyocyanin in supporting the infectivity of the doubly deficient mutant by its activity in the reductive release of soluble iron from transferrin (9) . In addition, a role for iron reductases excreted by P. aeruginosa (39) could be a matter of speculation. It is also possible that, in place of Pch and Pvd, some metabolites might participate as siderophores in iron acquisition. For example, salicylate, which is a precursor of Pch and may be produced after pchD inactivation with non-⍀ gene cartridge insertion (4, 34) as in our mutants (PAD02 and PAD07), could be a candidate (21) . However, further studies are needed to evaluate these possibilities.
We would propose, nevertheless, that the heme uptake system might be comparably important to siderophore-mediated systems for in vivo iron acquisition, because heme-containing proteins are very abundant in animal hosts and seem available as sources for efficient iron uptake (26) . In concert with the heme uptake system, it is likely that some pathogenic factors, including hemolysins and proteases, might work to damage cells and host proteins and to facilitate the release of heme, a mechanism similar to that by which proteases were supposed to promote siderophore-mediated iron acquisition from transferrin (13, 44) . As a heme uptake system in P. aeruginosa, the HasA (heme-binding protein)-mediated system has been partially characterized (16) . Moreover, an additional system that would involve a putative heme receptor, PhuR, might be present as suggested through the analysis of the P. aeruginosa genome (R. E. W. Hancock laboratory website [http://www.cmdr .ubc.ca/bobh/TonBfamily.html]; Pseudomonas Genome Proj-ect website [http://www.pseudomonas.com/]). Our proposal, the contribution of the heme uptake system to P. aeruginosa growth in vivo and virulence, could be supported by further studies using some genetically defined heme utilization mutants in the future, when the systems would be further characterized at the molecular and functional levels. In addition, recent advances in the analysis of the genome suggest that putative heme receptors (PhuR and HasR) of P. aeruginosa might be TonB dependent, as are receptors for Fe (III)-siderophore complexes (R. E. W. Hancock laboratory and Pseudomonas Genome Project websites). It is of interest to determine whether TonB protein (30) is essential for heme utilization in addition to siderophore-mediated iron acquisition, and also for infections by P. aeruginosa.
